Sustained impairment of IFN-γ secretion in suppressed HIV-infected patients despite mature NK cell recovery: Evidence for a defective reconstitution of innate immunity

Journal of Immunology

Volumn 168, Issue 11, 2002, Pages 5764-5770

  Azzoni, Livio ^a   Papasavvas, Emmanouil ^a   Chehimi, Jihed ^a   Kostman, Jay R ^a   Mounzer, Karam ^a   Ondercin, Joe ^a   Perussia, Bice ^a   Montaner, Luis J ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TARGET CELL; VIRUS LOAD; VIRUS RESISTANCE;

EID: 0036604132     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.11.5764     Document Type: Article

References (53)

1. Human immunodeficiency virus inhibits multilineage hematopoiesis in vivo
2. The influence of human immunodeficiency virus-1 on hematopoiesis
3. Human immunodeficiency virus-1 infection interrupts thymopoiesis and multilineage hematopoiesis in vivo
4. Effect of human immunodeficiency virus infection on hematopoiesis
5. Pathogenesis of the natural killer cell deficiency in AIDS
6. - cells with low lytic activity
7. + natural killer cell subset during HIV infection
8. - subset
9. Alterations in cytotoxic and phenotypic subsets of natural killer cells in acquired immune deficiency syndrome (AIDS)
10. Changes in natural immunity during the course of HIV-1 infection
11. Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection
12. Antibody-dependent cellular cytotoxicity in HIV infections
13. Defective natural immunity: An early manifestation of human immunodeficiency virus infection
14. Initial and innate responses to viral infections: Pattern setting in immunity or disease
15. NK cells and NKT cells in innate defense against viral infections
16. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
17. + patients produce C-C chemokines and inhibit HIV-1 infection
18. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro
19. + T cell subsets and induces early resistance to Leishmania major in mice
20. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis
21. + T cells through IL-12 produced by Listeria-induced macrophages
22. + T cells
23. Low production of interferon γ is related to disease progression in HIV infection: Evidence from a cohort of 347 HIV-infected individuals
24. + subjects
25. IL-13 and IFN-γ secretion by activated T cells in HIV-1 infection associated with viral suppression and a lack of disease progression
26. + patients: A randomized controlled trial
27. Low-dose daily interleukin-2 immunotherapy: Accelerating immune restoration and expanding HIV-specific T-cell immunity without toxicity
28. Reconstitution of NK cell activity in HIV-1 infected individuals receiving antiretroviral therapy
29. Immunological and virological changes in antiretroviral naive human immunodeficiency virus infected patients randomized to G-CSF or placebo simultaneously with initiation of HAART
30. + T cell counts of human immunodeficiency virus-infected patients receiving stable, highly active antiretroviral therapy: Results from a randomized, placebo-controlled trial
31. Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapy
32. Immune function and phenotype before and after highly active antiretroviral therapy
33. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells co-cultured with B lymphoblastoid cell lines
34. - functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12
35. Natural killer (NK) cell stimulatory factor (NKSF) increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients
36. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells
37. γ interferon and lymphotoxin, released by activated T cells, synergize to inhibit granulocyte/monocyte colony formation
38. - functionally immature human NK cell subset that differentiates in vitro in the presence of IL-12
39. + human natural killer cell progenitor that responds to interleukin-15
40. + hematopoietic progenitor cells
41. Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene factor, stem cell factor
42. Natural killer (NK) cell-mediated cytotoxicity: Differential use of TRAIL and Fas ligand by immature and mature primary human NK cells
43. Final steps of natural killer cell maturation: A model for type 1-type 2 differentiation?
44. Mechanisms of IFN-γ induction by natural killer cell stimulatory factor (NKSF/IL-12): Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2
45. Induction of interferon γ production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers
46. Human natural killer cells: A unique innate immunoregulatory role for the CD56 (bright) subset
47. Inhibition of natural killer cell cytotoxicity and interferon γ production by the envelope protein of HIV and prevention by vasoactive intestinal peptide
48. Natural immunity and HIV disease progression
49. Infection with human immunodeficiency virus type 1 up-regulates DNA methyltransferase, resulting in de novo methylation of the γ interferon (IFN-γ) promoter and subsequent down-regulation of IFN-γ production
50. + accessory cells in natural killing of cytomegalovirus-infected fibroblasts
51. + cell subsets in human peripheral blood
52. + cell production of interferon γ and the clinical spectrum of patients at risk for and with acquired immunodeficiency syndrome
53. Cytokine patterns during progression to AIDS in children with perinatal HIV infection